Browsing by Author Melero, I. (Ignacio)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 167  next >
Issue DateTitleTypeAuthor(s)
20204-1BB (CD137) in anticancer chimerasArticuloMelero, I. (Ignacio); Berraondo, P. (Pedro)
2021A burned-out CD8(+) T-cell subset expands in the tumor microenvironment and curbs cancer immunotherapyArticuloFernandez-Sanmamed, M. (Miguel); Nie, X. (Xinxin); Desai, S. (Shruti); Villaroel-Espíndola, F. (Franz); Badri, T. (Ti); Zhao, D. (Dejian); Kim, A.W. (Anthony W.); Ji, L. (Lan); Zhang, T. (Tianxiang); Quinlan, E. (Edward); Cheng, X. (Xiaoxiao); Han, X. (Xue); Vesely, M.D. (Matthew D.); Nassar, A.F. (Ala F.); Sun, J. (Jingwei); Zhang, Y. (Yu); Kim, T.K. (Tae Kon); Wang, J. (Jun); Melero, I. (Ignacio); Herbst, R.S. (Roy S.); Schalper, K.A. (Kurt A.); Chen, L. (Lieping)
2007A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseasesArticuloPalacios, R. (Ricardo); Goñi, J. (Joaquín); Martinez-Forero, I. (Iván); Iranzo, J. (Jaime); Sepulcre, J. (Jorge); Melero, I. (Ignacio); Villoslada, P. (Pablo)
2018A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasisArticuloGarcía-Rodríguez, J. (Javier); Castañon, E. (Eduardo); Perez-Gracia, J.L. (Jose Luis); Rodriguez, I. (Inmaculada); Viudez, A. (Antonio); Alfaro, C. (Carlos); Oñate, C. (Carmen); Perez, G. (Guiomar); Rotellar, F. (Fernando); Inoges, S. (Susana); Lopez-Diaz-de-Cerio, A. (Ascensión); Resano, L. (Leyre); Ponz-Sarvise, M. (Mariano); Rodriguez-Ruiz, M.E. (María Esperanza); Chopitea, A. (Ana); Vera, R. (Ruth); Melero, I. (Ignacio)
2018A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicityArticuloCompte, M. (Marta); Harwood, S.L. (Seandean Lykke); Muñoz, I.G. (Inés G.); Navarro, R. (Rocío); Zonca, M. (Manuela); Pérez-Chacon, G. (Gema); Erce-Llamazares, A. (Ainhoa); Merino, N. (Nekane); Tapia-Galisteo, A. (Alberto); Cuesta, A.M. (Ángel M.); Mikkelsen, K. (Kasper); Caleiras, E. (Eduardo); Núñez-Prado, N. (Natalia); Aznar, M.A. (María Ángela); Lykkemark, S. (Simon); Martínez-Torrecuadrada, J. (Jorge); Melero, I. (Ignacio); Blanco, F.J. (Francisco J.); Serna, J.B. (Jorge Bernardino) de la; Zapata, J.M. (Juan M.); Sanz, L. (Laura); Álvarez-Vallina, L. (Luis)
2004Active immunotherapy in the treatment of haematological neoplasiasArticuloInoges, S. (Susana); Rodriguez-Calvillo, M. (Mercedes); Lopez-Diaz-de-Cerio, A. (Ascensión); Zabalegui, N. (Natalia); Melero, I. (Ignacio); Sanchez-Ibarrola, A. (Alfonso); Rocha, E. (Eduardo); Bendandi, M. (Maurizio)
2000Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector levelArticuloMazzolini, G. (Guillermo); Qian, C. (Cheng); Narvaiza, I. (Íñigo); Barajas, M. (Miguel); Borras-Cuesta, F. (Francisco); Xie, X. (Xiaoming); Duarte, M. (Marina); Melero, I. (Ignacio); Prieto, J. (Jesús)
2022Advances in mRNA-based drug discovery in cancer immunotherapyArticuloDi-Trani, C.A. (Claudia Augusta); Fernández-Sendín, M. (Myriam); Cirella, A. (Assunta); Segués, A. (Aina); Olivera, I. (Irene); Bolaños, E. (Elixabet); Melero, I. (Ignacio); Berraondo, P. (Pedro)
2011Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytesArticuloPalazon, A. (Asís); Teijeira, A. (Álvaro); Martinez-Forero, I. (Iván); Hervas-Stubbs, S. (Sandra); Roncal, C. (Carmen); Peñuelas-Sanchez, I. (Ivan); Dubrot, J. (Juan); Morales-Kastresana, A. (Aizea); Perez-Gracia, J.L. (Jose Luis); Ochoa, M.C. (María Carmen); Ochoa, L. (Laura); Martinez, A. (Alfredo); Luque, A. (Alfonso); Dinchuk, J. (Joseph); Rouzaut, A. (Ana); Jure-Kunkel, M. (María); Melero, I. (Ignacio)
2001Alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitmentArticuloMazzolini, G. (Guillermo); Narvaiza, I. (Íñigo); Bustos, M. (Matilde); Duarte, M. (Marina); Tirapu, I. (Íñigo); Bilbao, R. (Roberto); Qian, C. (Cheng); Prieto, J. (Jesús); Melero, I. (Ignacio)
2002An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomasArticuloMelero, I. (Ignacio); Gabari, I. (Izaskun); Corbi, A.L. (Angel L.); Relloso, M. (Miguel); Mazzolini, G. (Guillermo); Schmitz, V. (Volker); Rodriguez-Calvillo, M. (Mercedes); Tirapu, I. (Íñigo); Camafeita, E. (Emilio); Albar, J.P. (Juan P.); Prieto, J. (Jesús)
2003Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell deathArticuloMelero, I. (Ignacio); Gabari, I. (Izaskun); Tirapu, I. (Íñigo); Arina, A. (Ainhoa); Mazzolini, G. (Guillermo); Baixeras, E. (Elena); Feijoo, E. (Esperanza); Alfaro, C. (Carlos); Qian, C. (Cheng); Prieto, J. (Jesús)
2018Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunityArticuloMartinez-Calle, N. (Nicolas); Rodriguez-Otero, P. (Paula); Villar-Fernández, S. (Sara); Mejías-Sosa, L.D. (Luis D.); Melero, I. (Ignacio); Prosper-Cardoso, F. (Felipe); Marinello, P. (Patricia); Paiva, B. (Bruno); Idoate, M.A. (Miguel Ángel); San-Miguel, J.F. (Jesús F.)
2020Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinomaArticuloSangro, B. (Bruno); Melero, I. (Ignacio); Wadhawan, S. (Samir); Finn, R.S. (Richard S.); Abou-Alfa, G.K. (Ghassan K.); Cheng, A.L. (Ann-Lii); Yau, T. (Thomas); Furuse, J. (Junji); Park, J.W. (Joong-Won); Boyd, Z. (Zachary); Tang, H.T. (Hao Tracy); Shen, Y. (Yun); Tschaika, M. (Marina); Neely, J. (Jaclyn); El-Khoueiry, A. (Anthony)
2004Biologic therapy of liver tumors.ArticuloPrieto, J. (Jesús); Qian, C. (Cheng); Sangro, B. (Bruno); Melero, I. (Ignacio); Mazzolini, G. (Guillermo)
2007Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's diseaseArticuloRodriguez, M. (Manuel); Alvarez-Erviti, L. (Lydia); Blesa, J. (Javier); Rodriguez-Oroz, M.C. (María Cruz); Arina, A. (Ainhoa); Melero, I. (Ignacio); Ramos, L.I. (Luis Isaac); Obeso, J.A. (José A.)
2020Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remediesArticuloPerez-Ruiz, E. (Elisabeth); Melero, I. (Ignacio); Kopecka, J. (Joanna); Sarmento-Ribeiro, A.B. (Ana Bela); García-Aranda, M. (Marilina); De-las-Rivas, J. (Javier)
2016Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cellsArticuloSanchez-Paulete, A.R. (Alfonso R.); Cueto, F.J. (Francisco J.); Martinez-Lopez, M. (María); Labiano, S. (Sara); Morales-Kastresana, A. (Aizea); Rodriguez-Ruiz, M.E. (María Esperanza); Jure-Kunkel, M. (María); Azpilicueta, A. (Arantza); Aznar, M.A. (María Ángela); Quetglas, J.I. (José Ignacio); Sancho, D. (David); Melero, I. (Ignacio)
2011Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulationArticuloAlfaro, C. (Carlos); Suarez, N. (Natalia); Martinez-Forero, I. (Iván); Palazon, A. (Asís); Rouzaut, A. (Ana); Solano, S. (Sarai); Feijoo, E. (Esperanza); Gurpide, A. (Alfonso); Bolaños, E. (Elixabet); Erro, L. (Lorena); Dubrot, J. (Juan); Hervas-Stubbs, S. (Sandra); Gonzalez-Hernandez, A. (Alvaro); Perez-Gracia, J.L. (Jose Luis); Melero, I. (Ignacio)
2003CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccinationArticuloCasares, N. (Noelia); Arribillaga, L. (Laura); Sarobe, P. (Pablo); Dotor, J. (Javier); Lopez-Diaz-de-Cerio, A. (Ascensión); Melero, I. (Ignacio); Lasarte, J.J. (Juan José)